MarkWide Research

Sale!

Bioreactors Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: July, 2022
No of Pages: 172
Delivery Format: PDF + Excel

$2,950.00

Bioreactors Market Overview:

The market for bioreactors was worth $2,615.4 million by 2020 and is projected to reach $7,328.4 million by 2030. It is projected to grow at an annual rate of 10.7 percent from 2021 to 2030.

The COVID-19 pandemic is predicted to have an impact on the development of the bioreactors market globally. The COVID-19 epidemic has strained the global health systems and increased the demand for monoclonal vaccines to prevent and treat patients with coronavirus. Numerous studies were carried out in cell culture mediums grown in bioreactors.

Bioreactors can be described as a device for manufacturing or a vessel through which biological reactions take place and are used to cultivate diverse organisms like yeast or bacteria or even animal cells in a suitable condition. They create a stable environment that promotes cell growth and the production of products. Bioreactors are employed in the biotechnology and pharmaceutical industries to create antibodies, vaccines, or other biologic products. They are also utilized in industrial processes to cultivate the organism in monitored conditions and create pharmaceutical products to treat chronic illness.

Increased demand for monoclonal antibiotics primarily drives the growth of the world bioreactors industry, an increase in the amount of money being provided by public and private organizations to develop vaccines, as well as a rise in the need for bioreactors with single-use applications, and the increase in research within the biotechnology and pharmaceutical sector. For instance, in the year 2019, Applicon Biotechnology, a manufacturing company that specializes in high-end bioprocess equipment, announced the launch of its single-use AppliFlex ST bioreactor at lab scale, which is a custom-designed bioreactor for single-use and comes with a pre-sterilized and ready to use system that will reduce time spent on setup. Furthermore, the increase in technology development for advanced bioreactors and advancements in the design of bioprocessing equipment will drive the growth of the market for bioreactors over the forecast time. In 2021, Beckman Coulter Life Science, a Danaher company involved in the healthcare research field, introduced its new Bio Lector XT Microbioreactor that will allow high-throughput strain screening and feeding strategy optimization and monitoring of the parameters of cultivation. The Bio Lector XT Microbioreactor can obtain high-quality information within a short period of time, using only the smallest amount of manual process.

Therefore, the presence of major companies in the production of advanced bioreactors, a rise in R&D activities related to the cultivation of cells and microbial applications, and the increase in clinical and preclinical trials will increase demand and accelerate the expansion of the market for bioreactors. However, the high price of bioreactors is anticipated to limit the market for bioreactors growth over the forecast period.

Bioreactors Market Segmentation

The market for bioreactors is segmented according to the type, use, control type, and area. The market is divided into stainless steel, glass, and single use. Based on the type of use, the market is classified into pilot-scale, lab-scale, and full-scale production. Based on the size, the market can be divided into 5L-20L, 20L-20L, 200L-1500L, and over 1500L. In terms of controlling type, the market is divided into automated and manual (MFCs).

The market is examined throughout North America (the U.S., Canada, and Mexico), Europe (Germany, France, and Europe (Germany, France, UK, Italy, Spain, and other parts of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and the rest of Asia-Pacific) as well as LAMEA (Brazil, Saudi Arabia, South Africa, and the rest of LAMEA).

Segment review

Based on the type, the single-use segment dominated the market in the year 2020 and is likely to maintain this pattern throughout the forecast timeframe due to the increasing demand for biological drugs and initiatives of the government to develop the pharmaceutical industry and the advancement of R&D processes for the production of vaccine. However, the glass market is anticipated to see significant growth in the market during the forecast time frame due to the increase in the demand for monoclonal antibiotics, technological advancements for advanced bioreactors, and the increase in the funding for biotechnological areas.

The single-Use segment was in the lead in 2020 and was expected to hold the lead throughout the forecast.

Based on the use and scale of production, the pilot-scale segment was the most popular in 2020 and is predicted to maintain this trend throughout the forecast time frame due to the increase in the incidence of chronic diseases as well as the development of the biotechnology and pharmaceutical industry, and an increase in numbers for preclinical and clinical trial studies. But the full-scale production segment is anticipated to experience significant growth over the forecast period due to the advancement in R&D initiatives for developing vaccines and the rapid adoption of advanced bioreactors.

Pilot-scale production is projected to be one of the most profitable segments.

Based on control type, the automated segment was dominant in the market in 2020 and is predicted to maintain this trend throughout the forecast period due to an increase in the incidence of chronic diseases as well as the rise in the use of the cell culture method and the advancement of R&D processes for the development of personalized medicines. But the manual segment is anticipated to see significant growth over the forecast period due to the increase in severity of chronic illness and the growth of the manufacturing of pharmaceuticals for the use of cell cultures, as well as the increase in the number of unemployed people.

The automated segment is predicted to be one of the most profitable segments.

North America accounted for a significant portion of the bioreactors market in the year 2020 and is anticipated to continue its dominance throughout the forecast timeframe due to the rising prevalence of chronic illnesses and the presence of major manufacturers of advanced bioreactors, and advances in R&D on biomedical studies within the region. But, Asia-Pacific is expected to achieve its highest CAGR of 12.3 percent between 2021 and 2030 due to an increase in the incidence of chronic illnesses, growth in the demand for new biologic medicines, and a rise in the amount pharmaceutical industry.

North America held a dominating position in 2020 and was expected to keep the lead.

The key players in the bioreactors market include BBI-Biotech GmbH Bioengineering AG, Danaher Corporation, Eppendorf AG, Getinge, Infos HT, Merck KGAA, Sartorius AG, Solaris Biotech Solutions as well as Thermo Fisher Scientific, Inc.

Key Benefits for Stakeholders

  • The report provides a thorough study of the market for bioreactors, current trends, and future estimates to help identify investment pockets that are likely to be forthcoming.
  • It offers a quantitative assessment of the market from 2021 until 2030, enabling those involved to profit from the current opportunities in the bioreactors market.
  • A thorough analysis of the market for bioreactors using procedures and services helps to comprehend the current trends in the field.
  • The key actors and their plans are studied to get a better understanding of the competitive landscape of the Bioreactors Market.
Bioreactors Market Report Scope and Segmentation 
 
ATTRIBUTESDETAILS
ESTIMATED YEAR2022
BASE YEAR2021
FORECAST YEAR2030
HISTORICAL YEAR2017-2021
UNITValue (USD Million/Billion)
BY REGIONNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

Key Market Segments

By Type

  • Glass
  • Stainless Steel
  • Single-Use

By Usage

  • Lab-Scale Production
  • Pilot-Scale Production
  • Full-Scale Production

By Scale

  • 5L-20L
  • 20L-200L
  • 200L-1500L
  • Above 1500L

By Control Type

  • Manual
  • Automated

Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Italy
    • France
    • UK
    • Spain
    • Poland
    • Russia
    • The Netherlands
    • Norway
    • Czech Republic
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Indonesia
    • Malaysia
    • Thailand
    • Singapore
    • Australia & New Zealand
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • The Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Northern Africa
    • Rest of MEA

Key Market Players

  • BBI-Biotech GmbH
  • Bioengineering AG
  • Danaher Corporation
  • Eppendorf AG
  • Getinge
  • Infor’s HT
  • Merck KGAA
  • Sartorius AG
  • Solaris Biotech Solutions
  • Thermo Fisher Scientific, Inc.

Table of Contents

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porters five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Advancements in R&D activities for novel biologic and microbial application
3.5.1.2.Rise in technological development for advanced bioreactors
3.5.1.3.Increase in demand for single-use bioreactors

3.5.2.Restraint

3.5.2.1.High cost of bioreactors

3.5.3.Opportunity

3.5.3.1.Increase in the development of biotechnology and pharmaceutical industry
3.5.4.Impact analysis

3.6.Impact analysis of COVID-19 on the bioreactors market

CHAPTER 4:BIOREACTORS MARKET , BY TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Single-Use

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market analysis, by Usage

4.3.Stainless steel

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.3.4.Market analysis, by Usage

4.4.Glass

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.4.4.Market analysis, by Usage

CHAPTER 5:BIOREACTORS MARKET , BY USAGE

5.1.Overview

5.1.1.Market size and forecast

5.3.Pilot-scale production

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country

5.4.Full-scale production

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country

5.5.Lab-scale production

5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by region
5.5.3.Market analysis, by country

CHAPTER 6:BIOREACTORS MARKET , BY SCALE

6.1.Overview

6.1.1.Market size and forecast

6.2.5L-20L

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country

6.3.20L-200L

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country

6.4.200L-1500L

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market analysis, by country

6.5.Above 1500L

6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by region
6.5.3.Market analysis, by country

CHAPTER 7:BIOREACTORS MARKET , BY CONTROL TYPE

7.1.Overview

7.1.1.Market size and forecast

7.2.Automated

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by region
7.2.3.Market analysis, by country

7.3.Manual

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by region
7.3.3.Market analysis, by country

CHAPTER 8:BIOREACTORS MARKET, BY REGION

8.1.Overview

8.1.1.Market size and forecast

8.2.North America

8.2.1.Key market trends, growth factors, and opportunities
8.2.2.North America bioreactors market, by type
8.2.3.North America bioreactors market, by usage
8.2.4.North America bioreactors market, by scale
8.2.5.North America bioreactors market, by control type
8.2.6.Market size and forecast, by country

8.2.6.1.U.S.

8.2.6.1.1.U.S. bioreactors market, by type
8.2.6.1.2.U.S. bioreactors market, by usage
8.2.6.1.3.U.S. bioreactors market, by scale
8.2.6.1.4.U.S. bioreactors market, by control type

8.2.6.2.Canada

8.2.6.2.1.Canada bioreactors market, by type
8.2.6.2.2.Canada bioreactors market, by usage
8.2.6.2.3.Canada bioreactors market, by scale
8.2.6.2.4.Canada bioreactors market, by control type

8.2.6.3.Mexico

8.2.6.3.1.Mexico bioreactors market, by type
8.2.6.3.2.Mexico bioreactors market, by usage
8.2.6.3.3.Mexico bioreactors market, by scale
8.2.6.3.4.Mexico bioreactors market, by control type

8.3.Europe

8.3.1.Key market trends, growth factors, and opportunities
8.3.2.Europe bioreactors market, by type
8.3.3.Europe bioreactors market, by usage
8.3.4.Europe bioreactors market, by scale
8.3.5.Europe bioreactors market, by control type
8.3.6.Market size and forecast, by country

8.3.6.1.Germany

8.3.6.1.1.Germany bioreactors market, by type
8.3.6.1.2.Germany bioreactors market, by usage
8.3.6.1.3.Germany bioreactors market, by scale
8.3.6.1.4.Germany bioreactors market, by control type

8.3.6.2.France

8.3.6.2.1.France bioreactors market, by type
8.3.6.2.2.France bioreactors market, by usage
8.3.6.2.3.France bioreactors market, by scale
8.3.6.2.4.France bioreactors market, by control type

8.3.6.3.UK

8.3.6.3.1.UK bioreactors market, by type
8.3.6.3.2.UK bioreactors market, by usage
8.3.6.3.3.UK bioreactors market, by scale
8.3.6.3.4.UK bioreactors market, by control type

8.3.6.4.Italy

8.3.6.4.1.Italy bioreactors market, by type
8.3.6.4.2.Italy bioreactors market, by usage
8.3.6.4.3.Italy bioreactors market, by scale
8.3.6.4.4.Italy bioreactors market, by control type

8.3.6.5.Spain

8.3.6.5.1.Spain bioreactors market, by type
8.3.6.5.2.Spain bioreactors market, by usage
8.3.6.5.3.Spain bioreactors market, by scale
8.3.6.5.4.Spain bioreactors market, by control type

8.3.6.6.Rest of Europe

8.3.6.6.1.Rest of Europe bioreactors market, by type
8.3.6.6.2.Rest of Europe bioreactors market, by usage
8.3.6.6.3.Rest of Europe bioreactors market, by scale
8.3.6.6.4.Rest of Europe bioreactors market, by control type

8.4.Asia-Pacific

8.4.1.Key market trends, growth factors, and opportunities
8.4.2.Asia-Pacific bioreactors market, by type
8.4.3.Asia-Pacific bioreactors market, by usage
8.4.4.Asia-Pacific bioreactors market, by scale
8.4.5.Asia-Pacific bioreactors market, by control type
8.4.6.Market size and forecast, by country

8.4.6.1.China

8.4.6.1.1.China bioreactors market, by type
8.4.6.1.2.China bioreactors market, by usage
8.4.6.1.3.China bioreactors market, by scale
8.4.6.1.4.China bioreactors market, by control type

8.4.6.2.Japan

8.4.6.2.1.Japan bioreactors market, by type
8.4.6.2.2.Japan bioreactors market, by usage
8.4.6.2.3.Japan bioreactors market, by scale
8.4.6.2.4.Japan bioreactors market, by control type

8.4.6.3.India

8.4.6.3.1.India bioreactors market, by type
8.4.6.3.2.India bioreactors market, by usage
8.4.6.3.3.India bioreactors market, by scale
8.4.6.3.4.India bioreactors market, by control type

8.4.6.4.Australia

8.4.6.4.1.Australia bioreactors market, by type
8.4.6.4.2.Australia bioreactors market, by usage
8.4.6.4.3.Australia bioreactors market, by scale
8.4.6.4.4.Australia bioreactors market, by control type

8.4.6.5.South Korea

8.4.6.5.1.South Korea bioreactors market, by type
8.4.6.5.2.South Korea. bioreactors market, by usage
8.4.6.5.3.South Korea bioreactors market, by scale
8.4.6.5.4.South Korea bioreactors market, by control type

8.4.6.6.Rest of Asia-Pacific

8.4.6.6.1.Rest of Asia-Pacific bioreactors market, by type
8.4.6.6.2.Rest of Asia-Pacific bioreactors market, by usage
8.4.6.6.3.Rest of Asia-Pacific bioreactors market, by scale
8.4.6.6.4.Rest of Asia-Pacific bioreactors market, by control type

8.5.LAMEA

8.5.1.Key market trends, growth factors, and opportunities
8.5.2.LAMEA bioreactors market, by type
8.5.3.LAMEA bioreactors market, by usage
8.5.4.LAMEA bioreactors market, by scale
8.5.5.LAMEA bioreactors market, by control type
8.5.6.Market size and forecast, by country

8.5.6.1.Brazil

8.5.6.1.1.Brazil bioreactors market, by type
8.5.6.1.2.Brazil bioreactors market, by usage
8.5.6.1.3.Brazil bioreactors market, by scale
8.5.6.1.4.Brazil bioreactors market, by control type

8.5.6.2.Saudi Arabia

8.5.6.2.1.Saudi Arabia bioreactors market, by type
8.5.6.2.2.Saudi Arabia bioreactors market, by usage
8.5.6.2.3.Saudi Arabia bioreactors market, by scale
8.5.6.2.4.Saudi Arabia bioreactors market, by control type

8.5.6.3.South Africa

8.5.6.3.1.South Africa bioreactors market, by type
8.5.6.3.2.South Africa bioreactors market, by usage
8.5.6.3.3.South Africa bioreactors market, by scale
8.5.6.3.4.South Africa bioreactors market, by control type

8.5.6.4.Rest of LAMEA

8.5.6.4.1.Rest of LAMEA bioreactors market, by type
8.5.6.4.2.Rest of LAMEA bioreactors market, by usage
8.5.6.4.3.Rest of LAMEA bioreactors market, by scale
8.5.6.4.4.Rest of LAMEA bioreactors market, by control type

CHAPTER 9:COMPANY PROFILES

9.1.BBI-BIOTECH GmbH

9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio

9.2.BIOENGINEERING AG.

9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio

9.3.DANAHER CORPORATION

9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Business performance
9.3.6.Key strategic moves and developments

9.4.EPPENDORF AG

9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance
9.4.6.Key strategic moves and developments

9.5.GETINGE

9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.5.5.Business performance
9.5.6.Key strategic moves and developments

9.6.INFORS HT

9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Key strategic moves and developments

9.7.MERCK KGAA

9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Business performance
9.7.6.Key strategic moves and developments

9.8.SARTORIUS AG

9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.8.6.Key strategic moves and developments

9.9.SOLARIS BIOTECH SOLUTIONS

9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio

9.10.THERMO FISHER SCIENTIFIC, INC.

9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Business performance
9.10.6.Key strategic moves and developments

LIST OF TABLES

TABLE 01.GLOBAL BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 02.BIOREACTORS MARKET FOR SINGLE-USE, BY REGION, 2020-2030 ($MILLION)
TABLE 03.BIOREACTORS MARKET FOR SINGLE-USE, BY USAGE, 2020-2030 ($MILLION)
TABLE 04.BIOREACTORS MARKET FOR STAINLESS STEEL, BY REGION, 2020-2030 ($MILLION)
TABLE 05.BIOREACTORS MARKET FOR STAINLESS STEEL, BY USAGE, 2020-2030 ($MILLION)
TABLE 06.BIOREACTORS MARKET FOR GLASS, BY REGION, 2020-2030 ($MILLION)
TABLE 07.BIOREACTORS MARKET FOR GLASS, BY USAGE, 2020-2030 ($MILLION)
TABLE 08.GLOBAL BIOREACTORS MARKET , BY USAGE, 2020-2030 ($MILLION)
TABLE 09.BIOREACTORS MARKET FOR PILOT-SCALE PRODUCTION, BY REGION, 2020-2030 ($MILLION)
TABLE 10.BIOREACTORS MARKET FOR FULL-SCALE PRODUCTION, BY REGION, 2020-2030 ($MILLION)
TABLE 11.BIOREACTORS MARKET FOR LAB-SCALE PRODUCTION, BY REGION, 2020-2030 ($MILLION)
TABLE 12.GLOBAL BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 13.BIOREACTORS MARKET FOR 5L-20L, BY REGION, 2020-2030 ($MILLION)
TABLE 14.BIOREACTORS MARKET FOR 20L-200L, BY REGION, 2020-2030 ($MILLION)
TABLE 15.BIOREACTORS MARKET FOR 200L-1500L, BY REGION, 2020-2030 ($MILLION)
TABLE 16.BIOREACTORS MARKET FOR ABOVE 1500L, BY REGION, 2020-2030 ($MILLION)
TABLE 17.GLOBAL BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 18.BIOREACTORS MARKET FOR AUTOMATED, BY REGION, 2020-2030 ($MILLION)
TABLE 19.BIOREACTORS MARKET FOR MANUAL, BY REGION, 2020-2030 ($MILLION)
TABLE 20.BIOREACTORS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 21.NORTH AMERICA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 22.NORTH AMERICA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 23.NORTH AMERICA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 24.NORTH AMERICA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 25.NORTH AMERICA BIOREACTORS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 26.U.S. BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 27.U.S. BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 28.U.S. BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 29.U.S. BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 30.CANADA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 31.CANADA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 32.CANADA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 33.CANADA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 34.MEXICO BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 35.MEXICO BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 36.MEXICO BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 37.MEXICO BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 38.EUROPE BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 39.EUROPE BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 40.EUROPE BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 41.EUROPE BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 42.EUROPE BIOREACTORS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 43.GERMANY BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 44.GERMANY BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 45.GERMANY BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 46.GERMANY BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 47.FRANCE BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 48.FRANCE BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 49.FRANCE BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 50.FRANCE BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 51.UK BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 52.UK BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 53.UK BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 54.UK BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 55.ITALY BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 56.ITALY BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 57.ITALY BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 58.ITALY BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 59.SPAIN BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 60.SPAIN BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 61.SPAIN BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 62.SPAIN BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 63.REST OF EUROPE BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 64.REST OF EUROPE BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 65.REST OF EUROPE BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 66.REST OF EUROPE BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 67.ASIA-PACIFIC BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 68.ASIA-PACIFIC BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 69.ASIA-PACIFIC BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 70.ASIA-PACIFIC BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 71.ASIA-PACIFIC BIOREACTORS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 72.CHINA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 73.CHINA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 74.CHINA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 75.CHINA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 76.JAPAN BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 77.JAPAN BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 78.JAPAN BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 79.JAPAN BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 80.INDIA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 81.INDIA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 82.INDIA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 83.INDIA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 84.AUSTRALIA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 85.AUSTRALIA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 86.AUSTRALIA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 87.AUSTRALIA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 88.SOUTH KOREA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 89.SOUTH KOREA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 90.SOUTH KOREA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 91.SOUTH KOREA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 92.REST OF ASIA-PACIFIC BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 93.REST OF ASIA-PACIFIC BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 94.REST OF ASIA-PACIFIC BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 95.REST OF ASIA-PACIFIC BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 96.LAMEA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 97.LAMEA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 98.LAMEA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 99.LAMEA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 100.LAMEA BIOREACTORS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 101.BRAZIL BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 102.BRAZIL BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 103.BRAZIL BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 104.BRAZIL BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 105.SAUDI ARABIA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 106.SAUDI ARABIA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 107.SAUDI ARABIA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 108.SAUDI ARABIA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 109.SOUTH AFRICA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 110.SOUTH AFRICA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 111.SOUTH AFRICA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 112.SOUTH AFRICA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 113.REST OF LAMEA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 114.REST OF LAMEA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 115.REST OF LAMEA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 116.BBI: COMPANY SNAPSHOT
TABLE 117.BBI: OPERATING SEGMENTS
TABLE 118.BBI: PRODUCT PORTFOLIO
TABLE 119.BIOENGINEERING: COMPANY SNAPSHOT
TABLE 120.BIOENGINEERING: OPERATING BUSINESS SEGMENTS
TABLE 121.BIOENGINEERING: PRODUCT PORTFOLIO
TABLE 122.DANAHER: COMPANY SNAPSHOT
TABLE 123.DANAHER: PRODUCT SEGMENTS
TABLE 124.DANAHER: PRODUCT PORTFOLIO
TABLE 125.DANAHER: KEY DEVELOPMENTS
TABLE 126.EPPENDORF: COMPANY SNAPSHOT
TABLE 127.EPPENDORF: OPERATING SEGMENTS
TABLE 128.EPPENDORF: PRODUCT PORTFOLIO
TABLE 129.EPPENDORF: KEY DEVELOPMENTS
TABLE 130.GETINGE: COMPANY SNAPSHOT
TABLE 131.GETINGE: OPERATING BUSINESS SEGMENTS
TABLE 132.GETINGE: PRODUCT PORTFOLIO
TABLE 133.GETINGE: KEY DEVELOPMENTS
TABLE 134.INFORS: COMPANY SNAPSHOT
TABLE 135.INFORS: OPERATING SEGMENTS
TABLE 136.INFORS: PRODUCT PORTFOLIO
TABLE 137.INFORS: KEY DEVELOPMENTS
TABLE 138.MERCK: COMPANY SNAPSHOT
TABLE 139.MERCK: OPERATING SEGMENTS
TABLE 140.MERCK: PRODUCT PORTFOLIO
TABLE 141.MERCK: KEY DEVELOPMENTS
TABLE 142.SARTORIUS: COMPANY SNAPSHOT
TABLE 143.SARTORIUS: PRODUCT SEGMENTS
TABLE 144.SARTORIUS: PRODUCT PORTFOLIO
TABLE 145.SARTORIUS: KEY DEVELOPMENTS
TABLE 146.SOLARIS: COMPANY SNAPSHOT
TABLE 147.SOLARIS: PRODUCT SEGMENTS
TABLE 148.SOLARIS: PRODUCT PORTFOLIO
TABLE 149.THERMO FISHER: COMPANY SNAPSHOT
TABLE 150.THERMO FISHER: OPERATING SEGMENTS
TABLE 151.THERMO FISHER: PRODUCT PORTFOLIO
TABLE 152.THERMO FISHER: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 01.BIOREACTORS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 20182021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 20182021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 20182021
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR SINGLE-USE, BY COUNTRY, 2020-2030 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR STAINLESS STEEL, BY COUNTRY, 2020-2030 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR GLASS, BY COUNTRY, 2020-2030 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR PILOT-SCALE PRODUCTION, BY COUNTRY, 2020-2030 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR FULL-SCALE PRODUCTION, BY COUNTRY, 2020-2030 (%)
FIGURE 18.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR LAB-SCALE PRODUCTION, BY COUNTRY, 2020-2030 (%)
FIGURE 19.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR 5L-20L, BY COUNTRY, 2020-2030 (%)
FIGURE 20.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR 20L-200L, BY COUNTRY, 2020-2030 (%)
FIGURE 21.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR 200L-1500L, BY COUNTRY, 2020-2030 (%)
FIGURE 22.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR ABOVE 1500, BY COUNTRY, 2020-2030 (%)
FIGURE 23.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR AUTOMATED, BY COUNTRY, 2020-2030 (%)
FIGURE 24.COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR MANUAL, BY COUNTRY, 2020-2030 (%)
FIGURE 25.DANAHER: NET SALES, 20182020 ($MILLION)
FIGURE 26.DANAHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 27.DANAHER: REVENUE SHARE BY REGION, 2020(%)
FIGURE 28.EPPENDORF: NET SALES, 20182020 ($MILLION)
FIGURE 29.EPPENDORF: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 30.EPPENDORF: REVENUE SHARE BY REGION, 2020(%)
FIGURE 31.GETINGE: NET SALES, 20182020 ($MILLION)
FIGURE 32.GETINGE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 33.GETINGE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 34.MERCK: NET SALES, 20182020 ($MILLION)
FIGURE 35.MERCK: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 36.MERCK: REVENUE SHARE BY REGION, 2020(%)
FIGURE 37.SARTORIUS: NET SALES, 20182020 ($MILLION)
FIGURE 38.SARTORIUS: REVENUE SHARE BY SEGMENT, 2020 (%)

Major Companies

  • BBI-Biotech GmbH
  • Bioengineering AG
  • Danaher Corporation
  • Eppendorf AG
  • Getinge
  • Infor’s HT
  • Merck KGAA
  • Sartorius AG
  • Solaris Biotech Solutions
  • Thermo Fisher Scientific, Inc.

Major Segmentation

By Type

  • Glass
  • Stainless Steel
  • Single-Use

By Usage

  • Lab-Scale Production
  • Pilot-Scale Production
  • Full-Scale Production

By Scale

  • 5L-20L
  • 20L-200L
  • 200L-1500L
  • Above 1500L

By Control Type

  • Manual
  • Automated

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF